<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02377180</url>
  </required_header>
  <id_info>
    <org_study_id>066/13</org_study_id>
    <nct_id>NCT02377180</nct_id>
  </id_info>
  <brief_title>Capsaicin-induced Muscle Pain in Humans</brief_title>
  <official_title>Capsaicin-induced Muscle Pain in Humans: From Investigating Central Pain Processing to Developing Clinical Applications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aalborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is currently no specific diagnostic test for primary muscular pain. The present study&#xD;
      investigates whether selective blockade of the suprascapular nerve can effectively abolish&#xD;
      experimental pain arising from the supraspinatus muscle. Experimental muscle pain is induced&#xD;
      by intramuscular injection of capsaicin, an alkaloid from red chili peppers. The study&#xD;
      consists of three parts:&#xD;
&#xD;
        1. to describe the development, time course and intensity of capsaicin-induced muscle pain&#xD;
&#xD;
        2. to evaluate the effectiveness of suprascapular nerve block against capsaicin-induced&#xD;
           muscle pain&#xD;
&#xD;
        3. to compare suprascapular nerve block and direct intramuscular local anesthetic&#xD;
           infiltration for their effectiveness in capsaicin-induced muscle pain&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background&#xD;
&#xD;
      Musculoskeletal pain is one of the most common reasons for consulting a physician. Many&#xD;
      musculoskeletal pain disorders are associated with a widespread decrease in pain thresholds,&#xD;
      indicating a state of hyperexcitability of the central nervous system.&#xD;
&#xD;
      This central hypersensitivity can be assessed by measuring pain thresholds to different&#xD;
      experimental stimuli, using so-called quantitative sensory tests (QST).&#xD;
&#xD;
      Several experimental pain models are being used in healthy volunteers in order to study the&#xD;
      central mechanisms of pain processing. Injection of capsaicin is one of them, which is&#xD;
      associated with spreading of local pain, development of referred pain and hyperalgesia to&#xD;
      thermal, mechanical or electrical stimuli.&#xD;
&#xD;
      Intramuscular injection of capsaicin is therefore potentially interesting for investigating&#xD;
      primary muscle pain, central hypersensitivity and endogenous pain modulation. The present&#xD;
      research project comprises three substudies which use intramuscular capsaicin to detect&#xD;
      changes in central pain processing and to evaluate clinical tools for the diagnosis of&#xD;
      primary muscle pain.&#xD;
&#xD;
      Part 1: The investigators hypothesize that the intensity, duration and expansion area of&#xD;
      capsaicin-induced muscle pain depends on a subject's endogenous pain modulation. The&#xD;
      investigators expect that subjects with strong endogenous pain modulation develop less pain&#xD;
      and hyperalgesia after capsaicin injection than subjects with poor endogenous pain&#xD;
      modulation. A large sample of healthy volunteers will therefore be screened using QST and&#xD;
      then recruited for capsaicin injection if they show either very strong or very weak&#xD;
      endogenous pain modulation. The data of the whole sample can be used to determine normative&#xD;
      values of endogenous pain modulation.&#xD;
&#xD;
      Part 2 investigates the ability of suprascapular nerve block to abolish primary muscle pain.&#xD;
      Healthy volunteers will receive capsaicin injection into the supraspinatus muscle or the&#xD;
      trapezius muscle as a control condition in a randomized, blinded fashion. The investigators&#xD;
      expect that the nerve block is more effective in the former compared to the latter muscle.&#xD;
&#xD;
      Part 3 compares the analgesic efficacy of suprascapular nerve block and direct intramuscular&#xD;
      local anesthetic infiltration of the supraspinatus muscle after capsaicin injection. This&#xD;
      will determine which procedure is more effective to treat primary muscle pain.&#xD;
&#xD;
      Objective&#xD;
&#xD;
        1. To determine normative values for endogenous pain modulation in healthy volunteers&#xD;
&#xD;
        2. To demonstrate that capsaicin-induced pain and hyperalgesia depend on endogenous pain&#xD;
           modulation&#xD;
&#xD;
        3. To calculate sensitivity and specificity of suprascapular nerve block for the diagnosis&#xD;
           of primary muscle pain&#xD;
&#xD;
        4. To determine whether suprascapular nerve block or intramuscular local anesthetic&#xD;
           infiltration are more effective against muscle pain&#xD;
&#xD;
      Methods&#xD;
&#xD;
        1. intramuscular injection of capsaicin&#xD;
&#xD;
        2. quantitative sensory tests (pressure pain thresholds)&#xD;
&#xD;
        3. ultrasound-guided suprascapular nerve block&#xD;
&#xD;
        4. ultrasound-guided intramuscular local anesthetic infiltration&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intensity of shoulder pain on numeric rating scale</measure>
    <time_frame>two hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pressure pain thresholds</measure>
    <time_frame>two hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of referred pain</measure>
    <time_frame>two hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Part 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intramuscular injection of capsaicin for the study of pain and hyperalgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pain arising from supraspinatus muscle vs. pain arising from trapezius muscle. Nerve block is only expected to be effective in the former.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Part 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Suprascapular nerve block vs. intramuscular local anesthetic against pain arising from the supraspinatus muscle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intramuscular capsaicin injection</intervention_name>
    <description>Intramuscular injection of capsaicin: 50 mcg/0.5 ml</description>
    <arm_group_label>Part 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Suprascapular nerve block</intervention_name>
    <description>Injection of capsaicin 50 mcg/0.5 ml into the supraspinatus or trapezius muscle in randomized order, followed by suprascapular nerve block (ultrasound-guided) using Lidocaine 1%; nerve block is expected to be effective only in pain arising from the supraspinatus muscle. Trapezius pain serves as control condition.&#xD;
Evaluates the diagnostic validity of suprascapular nerve block for muscle pain.</description>
    <arm_group_label>Part 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local anesthetic infiltration</intervention_name>
    <description>Injection of capsaicin 50 mcg/0.5 ml into the supraspinatus muscle in two different sessions; suprascapular nerve block in one session and intramuscular local anesthetic infiltration in one session (in randomized order) using Lidocaine 1%; the aim is to investigate which procedure provides faster and more efficient pain relief. Compares effectivity of suprascapular nerve block vs. intramuscular local anesthetic infiltration.</description>
    <arm_group_label>Part 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-80 years&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Any acute pain at the moment of testing&#xD;
&#xD;
          -  Intake of analgesics 24hours before testing&#xD;
&#xD;
          -  Intake of antidepressants, anticonvulsants or benzodiazepines&#xD;
&#xD;
          -  Allergy to local anesthetic or skin disinfectant&#xD;
&#xD;
          -  Pregnancy or breast-feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michele Curatolo, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology and Pain Therapy, University of Washington, Seattle WA, USA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Department of Anesthesiology and Pain Therapy,Inselspital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Graven-Nielsen T, Gibson SJ, Laursen RJ, Svensson P, Arendt-Nielsen L. Opioid-insensitive hypoalgesia to mechanical stimuli at sites ipsilateral and contralateral to experimental muscle pain in human volunteers. Exp Brain Res. 2002 Sep;146(2):213-22. Epub 2002 Jul 13.</citation>
    <PMID>12195523</PMID>
  </reference>
  <reference>
    <citation>Witting N, Svensson P, Gottrup H, Arendt-Nielsen L, Jensen TS. Intramuscular and intradermal injection of capsaicin: a comparison of local and referred pain. Pain. 2000 Feb;84(2-3):407-12.</citation>
    <PMID>10666547</PMID>
  </reference>
  <reference>
    <citation>Siegenthaler A, Moriggl B, Mlekusch S, Schliessbach J, Haug M, Curatolo M, Eichenberger U. Ultrasound-guided suprascapular nerve block, description of a novel supraclavicular approach. Reg Anesth Pain Med. 2012 May-Jun;37(3):325-8. doi: 10.1097/AAP.0b013e3182409168.</citation>
    <PMID>22222688</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>February 11, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>January 16, 2017</last_update_submitted>
  <last_update_submitted_qc>January 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>musculoskeletal pain</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>diagnostic nerve block</keyword>
  <keyword>intramuscular capsaicin</keyword>
  <keyword>referred pain</keyword>
  <keyword>hyperalgesia</keyword>
  <keyword>experimental pain</keyword>
  <keyword>central hypersensitivity</keyword>
  <keyword>human experimental pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myalgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Capsaicin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

